DIA
ARRY

Denver Investment Advisors’s Array Biopharma Inc ARRY Stock Holding History

Denver Investment Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$478K Buy
+29,289
New +$469K 0.03% 325
2014
Q3 		– Sell
-42,903
Closed -$196K – 647
2014
Q2 		$196K Buy
42,903
+16,267
+61% +$67.3K 0.01% 549
2014
Q1 		$125K Buy
26,636
+9,134
+52% +$45.9K ﹤0.01% 588
2013
Q4 		$88 Buy
17,502
+1,897
+12% +$10.3K ﹤0.01% 559
2013
Q3 		$97K Buy
15,605
+4,817
+45% +$28.6K ﹤0.01% 560
2013
Q2 		$49K Buy
+10,788
New +$58K ﹤0.01% 545

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Denver Investment Advisors's ARRY Position: Q1 2018 in Review

Denver Investment Advisors opened a new position in Array Biopharma Inc (ARRY) in Q1 2018: 29,289 shares worth $478K. The stake represents 0.03% of the portfolio and ranks #325 among its holdings. This is a return to the name: Denver Investment Advisors previously reported a position in ARRY as recently as Q2 2014.

Denver Investment Advisors first reported a position in ARRY in Q2 2013 and has held it in 6 quarters since. 235 funds tracked by Wall St. Rank hold ARRY as of Q1 2018.

  • Denver Investment Advisors held 29,289 shares of Array Biopharma Inc worth $478K as of Q1 2018.
  • Array Biopharma Inc was a new Denver Investment Advisors position in Q1 2018.
  • Array Biopharma Inc made up 0.03% of Denver Investment Advisors's portfolio in Q1 2018, its #325 holding.
  • Denver Investment Advisors first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 6 quarters since.
  • 235 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.